Advancing Pain Management Science and Education: ASRA Special Session Featured

1:30 PM - 3:00 PM Friday, January 24

This session will highlight recent advances in understanding for chronic pain management that influence procedural outcomes. The session will define the influence of opioids on surgical outcomes and methods to mitigate the negative effects. Contrast hypersensitivity reactions will be explored and best practices will be defined. Recent concerns regarding gadolinium-based contrast agents including brain deposition and acute neurotoxicity will be characterized. Furthermore, the significant concerns surrounding gadolinium use as an alternative contrast agent in individuals with iodinated contrast hypersensitivity reactions will be explored. The future of interventional headache care will be explored. The session will also analyze the current research on analgesic pharmacological and interventional therapies and their impact on cancer disease progression and recurrence.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Define opioids' influence on surgical outcomes and methods to mitigate the negative medical consequences.
  • Identify radiographic contrast hypersensitivity reactions and gadolinium deposition and neurotoxicity.
  • Describe interventional headache medicine.
  • Review the current research on analgesic therapies and their impact on cancer disease progression.

Opioid's Sequelae on Surgical Outcomes

Eugene R. Viscusi, MD

Interventional Headache Medicine: A New Subspecialty

Samer N. Narouze, MD PhD

Imaging Safety in Interventional Pain Medicine: Contrast Selection and Reactions

David A. Provenzano, MD

Impact of Perioperative Pain Management on Cancer Recurrence: An ASRA/ESRA Special Article

Oscar A. de Leon-Casasola, MD

Faculty and Presentations subject to change.